Drug wholesaler Cardinal Health Inc. this morning announced that it would buy Boron, LePore & Associates Inc., a provider of promotional, marketing and educational information for the pharmaceutical industry, for more than $190 million. Cardinal, based in Dublin, Ohio, said it will make a cash tender offer of $16 a share for Boron, LePore; Boron's shares closed at $13.33 on Tuesday on Nasdaq. As of the first quarter, Boron, LePore had about 12.1 million shares outstanding. Cardinal ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.